From: Digitoxin medication and cancer; case control and internal dose-response studies
ICD-10 | Site | Sex | Observed | Expected | SIR (95 % CI) |
---|---|---|---|---|---|
C50 | Breast | F | 57 | 45.7 | 1.25(0.95, 1.62) |
C61 | Prostate | M | 108 | 86.7 | 1.25(1.03, 1.50) |
C18–21 | Colo-rectal | M+F | 127 | 98.5 | 1.29(1.06, 1.51) |
C32–34 | Lung | M+F | 63 | 46.4 | 1.35(1.04, 1.74) |
C64,C65,C67,C68 | Kidney, urinary | M+F | 59 | 51.8 | 1.14(0.87, 1.47) |
C43.C44 | Melanoma, other skin | M+F | 61 | 49.7 | 1.23(0.94, 1.58) |
C81–C85,C88–C92 | Leukemia/Lymphoma | M+F | 53 | 37.5 | 1.41 (1.06, 1.85) |
C00–C97 | All sites | M+F | 641 | 502.8 | 1.27(1.18, 1.37) |